The Core serves several functions. First, it is essential for administration of the Program Project as a whole. Most of these functions are the responsibility of Stephen Krane who has been a Co- Program Director since 1961, shortly after the Program took effect. Second, the Core provides support for common activities of the investigators in each of the projects. Since as a group we make considerable use of cell culture, upkeep of equipment for this purpose as well as supplies and preparation of medium are major functions of the Core. Mary Goldring, who is Principal Investigator of Project 3 and has major expertise in this area, will therefore assume new responsibilities related to the Core for a 10% time commitment. In addition, we plan coordinate the use of reagents such as restriction endonucleases and various kits used in molecular biological approaches for optimal efficiency. The Core also provides for support of a glasswasher, Matilde Tanner, who has been with our group for more than two decades. Third, the Core provides for secretarial support for the entire Program Project. Michele Angelo is Executive Office Assistant who has been associated with the Arthritis Unit for several years. She will continue to have a major role in running the day-to-day functions of the Program Project in addition to her secretarial responsibilities. We have also budgeted a position for a part-time secretary, presently occupied by Rhonda Kysilovsky. This second position is essential in view of the separation of our laboratories in Charleston from the offices on the main MGH campus.

Project Start
Project End
Budget Start
Budget End
Support Year
37
Fiscal Year
1996
Total Cost
Indirect Cost
Krane, Stephen M; Inada, Masaki (2008) Matrix metalloproteinases and bone. Bone 43:7-18
Krane, Stephen M (2003) Elucidation of the potential roles of matrix metalloproteinases in skeletal biology. Arthritis Res Ther 5:2-4
Riquet, F B; Tan, L; Choy, B K et al. (2001) YY1 is a positive regulator of transcription of the Col1a1 gene. J Biol Chem 276:38665-72
Riquet, F B; Lai, W F; Birkhead, J R et al. (2000) Suppression of type I collagen gene expression by prostaglandins in fibroblasts is mediated at the transcriptional level. Mol Med 6:705-19
Kokenyesi, R; Tan, L; Robbins, J R et al. (2000) Proteoglycan production by immortalized human chondrocyte cell lines cultured under conditions that promote expression of the differentiated phenotype. Arch Biochem Biophys 383:79-90
Gravallese, E M; Manning, C; Tsay, A et al. (2000) Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43:250-8
Zhao, W; Byrne, M H; Wang, Y et al. (2000) Osteocyte and osteoblast apoptosis and excessive bone deposition accompany failure of collagenase cleavage of collagen. J Clin Invest 106:941-9
Orcel, P; Tajima, H; Murayama, Y et al. (2000) Multiple domains interacting with Gs in the porcine calcitonin receptor. Mol Endocrinol 14:170-82
Inoue, D; Shih, C; Galson, D L et al. (1999) Calcitonin-dependent down-regulation of the mouse C1a calcitonin receptor in cells of the osteoclast lineage involves a transcriptional mechanism. Endocrinology 140:1060-8
Zhao, W; Byrne, M H; Boyce, B F et al. (1999) Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. J Clin Invest 103:517-24

Showing the most recent 10 out of 60 publications